Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Oct 21;100(17):adv00300.
doi: 10.2340/00015555-3668.

Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis

Tsung-Yu Tsai  1 , Ying-Yi Chiang, Yu-Chen Huang
Affiliations
Meta-Analysis

Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis

Tsung-Yu Tsai et al. Acta Derm Venereol. .

Abstract

The association between rosacea and cardiovascular disease remains controversial. A systematic review and meta-analysis of the literature, from inception to 15 February 2020, was performed to compare cardiovascular risk and comorbidities in individuals with and without rosacea. Twelve studies, involving 40,752 patients with rosacea, were included. Compared with controls, patients with rosacea had higher systolic blood pressure (standardized mean difference (SMD) 0.293, 95% confidence interval (CI) 0.054-0.532), diastolic blood pressure (SMD 0.309, 95% CI 0.003-0.615), total cholesterol (SMD 1.147, 95% CI 0.309-1.984), low-density lipoprotein (SMD 0.792, 95% CI 0.174-1.409), C-reactive protein (SMD 0.26, 95% CI 0.099-0.421), greater epicardial fat thickness (SMD 1.945, 95% CI 1.595-2.296), and higher incidence of hypertension (odds ratio (OR) 1.204, 95% CI 1.097-1.332) and insulin resistance (OR 2.338, 95% CI 1.187-4.605). This study reveals that patients with rosacea are predisposed to increased subclinical cardiovascular risk.

Keywords: dyslipidaemia; hypertension; meta-analysis; risk factor; rosacea; systematic review; cardiovascular disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Flow diagram for study identification.
Fig. 2
Fig. 2
Forest plots. The forest plots showed the pooled estimates of cardiovascular risk factors in patients with rosacea in comparison with controls. Compared with controls, patients with rosacea had higher systolic blood pressure, diastolic blood pressure, total cholesterol, low-density lipoprotein, and C-reactive protein. Carotid intima media thickness was similar between patients with rosacea and controls, but epicardial fat thickness was greater in rosacea patients than in controls. CI: confidence interval.
Fig. 3
Fig. 3
Forest plots. Pooled analyses showed the incidence of hypertension and insulin resistance was significantly higher in patients with rosacea than in controls, but the incidence of metabolic syndrome and diabetes mellitus was similar in the 2 groups. CI: confidence interval.
See this image and copyright information in PMC

References

    1. Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, et al. . Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018; 78: 148–155. - PubMed
    1. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci 2009; 55: 77–81. - PMC - PubMed
    1. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, et al. . Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975–980. - PubMed
    1. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 2013; 69: S15–S26. - PubMed
    1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695. - PubMed